| Literature DB >> 25763047 |
Mariana Fávero Bonesso1, Silvio Alencar Marques2, Carlos Henrique Camargo3, Carlos Magno Castelo Branco Fortaleza4, Maria de Lourdes Ribeiro de Souza da Cunha3.
Abstract
The aim of this study was to determine the prevalence of Staphylococcus aureus and risk factors for the acquisition of MRSA (Methicillin Resistant Staphylococcus aureus) as the main cause of skin and soft tissue infections. S. aureus were characterized for the presence of PVL, TSST-1 and mecA genes. SCCmec typing was carried out in mecA positive strains and PFGE was performed only in these strains. During the study period, 127 outpatients attending a dermatology clinical the Botucatu Medical School, a regional tertiary hospital in Botucatu, Sao Paulo, Brazil, were diagnosed with active skin infections. A total 66 (56.9%) S. aureus strains were isolated. The methicillin resistance gene mecA was detected in seven (10.6%) S. aureus strains. The SCCmec types detected in the seven mecA-positive S. aureus strains were type Ia in one, type II in three, and type IV in three. The PVL gene was detected in 10 (15.1%) in sensitive strains. Pulsed field gel electrophoresis revealed non-clonal diversity among the isolates. The risk factors associated with MRSA acquisition in this study were previous ciprofloxacin use and working in a healthcare environment. The risk factors indicate plausible routes of CA-MRSA transmission among the subjects studied.Entities:
Keywords: Staphylococcus aureus; epidemiology; resistance; skin infections; virulence
Mesh:
Substances:
Year: 2015 PMID: 25763047 PMCID: PMC4323316 DOI: 10.1590/s1517-83822014000400034
Source DB: PubMed Journal: Braz J Microbiol ISSN: 1517-8382 Impact factor: 2.476
Figure 1PFGE analysis of MRSA isolates from skin and soft tissue infections. Three SCCmec II samples (070, 064 and 126) had identical profiles, while three SCCmec IV samples (064, 022 and 038) grouped with high similarity, and one sample (016) could not be allocated in any group.
Statistical analysis ofdemographic data. Univariate and Multivariate analysis reveal the previous use of ciprofloxacin as a risk factor for CA-MRSA acquisition, and multivariate analysis showed that healthcare work was a risk factor. The risk factor in univariate analysis is highlighted in red and the values (number of cases, non-cases, OR and p values) are in bold. We highlighted in yellow the additional risk factors according to multivatiate analysis.
| Risk factor | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
|
|
| |||||
| Cases (n = 7) | Non-cases (n = 119) | OR (95%CI) | p | OR (95%CI) | p | |
| Demographic data | ||||||
| Female gender | 6 (89.7) | 57 (47.9) | 6.53 (0.76–55.88) | 0.052 | ||
| Age in years mean | 48 (13–72) | 46 (0–82) | ... | 0.64 | ||
| Urban residence | 7 (100.0) | 107 (89.9) | ... | 1.00 | ||
| Working in a rural area | 1 (14.3) | 16 (13.4) | 1.07 (0.12–9.51) | 1.00 | ||
| Working in a healthcare environment | 1 (14.3) | 2 (1.7) | 9.75 (0.77–123.23) | 0.16 | ||
| Retired | 2 (28.6) | 18 (15.1) | 2.24 (0.40–12.57) | 0.31 | ||
| Wage > R$ 1 000.00 per month | 2 (28.6) | 35 (29.4) | 0.96 (0.18–5.19) | 1.00 | ||
| Previous hospital admission and procedures | ||||||
| Previous hospital admission | 2 (28.6) | 20 (16.8) | 1.98 (0.36–10.93) | 0.61 | ||
| Previous surgery | 1 (14.3) | 10 (8.4) | 1.82 (0.20–16.62) | 0.48 | ||
| Abscess drainage | 0 (0.0) | 6 (5.0) | 0.0 (...) | 1.00 | ||
| Underlying comorbidity | ||||||
| Diabetes mellitus | 2 (28.6) | 21 (17.6) | 1.87 (0.34–10.28) | 0.61 | ||
| Use of insulin | 1 (14.3) | 6 (5.0) | 3.14 (0.32–30.40) | 0.34 | ||
| Underlying dermatological disease | 0 (0.0) | 4 (3.4) | 0.0 (...) | 1.00 | ||
| Characteristics of present infection | ||||||
| Secondary to local trauma | 3 (42.9) | 49 (41.2) | 1.07 (0.23–5.00) | 1.00 | ||
| Duration > 30 days | 4 (57.1) | 56 (47.1) | 1.50 (0.32–6.99) | 0.78 | ||
| History of antibiotic use | ||||||
| Any antibiotic | 4 (57.1) | 40 (33.6) | 2.63 (0.56–12.34) | 0.24 | ||
| Penicillin benzathine | 0 | 2 (1.7) | 0.0 (...) | 1.00 | ||
| Amoxicillin | 2 (18.6) | 16 (13.4) | 2.58 (0.46–14.14) | 0.26 | ||
| Cephalexin | 0 (0.0) | 26 (21.4) | 0.0 (...) | 0.34 | ||
| Clindamycin | 2 (28.6) | 11 (9.2) | 3.93 (0.68–22.67) | 0.15 | ||
| Ciprofloxacin | ||||||
| Macrolides | 0 (0.0) | 3 (2.5) | 0.0 (...) | 1.00 | ||
| Other | ||||||
| Participation in sports | 0 (0.0) | 17 (14.3) | 0.0 (...) | 0.59 | ||
| Use of illicit drugs | 0 (0.0) | 12 (10.1) | 0.0 (...) | 1.00 | ||
Results are numbers (percentage), unless otherwise stated.
Approximately US$ 500.00 per month.
OR, odds ratio; CI, confidence interval.